New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 25, 2013
09:26 EDTCYTXCytori Therapeutics receives CE Mark in Europe for Intravase
Cytori Therapeutics has received a CE Mark in Europe for Intravase, a reagent intended to be used with Cytori’s Celution System for preparing safe and optimized adipose-derived stem and regenerative cells for intravascular delivery into the same patient.
News For CYTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 12, 2015
06:43 EDTCYTXCytori Therapeutics coverage assumed with a Buy at Ascendiant
Subscribe for More Information
May 11, 2015
16:29 EDTCYTXCytori Therapeutics reports Q1 EPS ex-charge (7c), consensus 7c
Reports Q1 revenue $902,000, consensus $2.44M. Reports cash and debt balances at March 31 of approximately $13.2M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use